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Background
Mental illness is a major source of disease burden in the 
United Kingdom, costing in the region of £105 billion 
pounds.1 Psychosis is a severe form of mental illness that has 
huge social, economic and personal costs.2 The disorder has 
the highest prevalence in the young population between 15 
and 35 years of age.3 Individuals who experience psychosis 
may encounter a number of symptoms such as perceptual 
phenomena, including auditory hallucinations and delusional 
ideation or other disturbances in thinking.4 At later stages of 
the disorder, there may be a marked deterioration in an indi-
vidual’s functioning.5
The UK National Health Service (NHS England) Improving 
Access to Psychological Therapies for Severe Mental Illness 
(IAPT-SMI) initiative aims to increase the availability of psy-
chological interventions.6 Despite such initiatives, access to 
psychological treatments is low, with individuals experiencing 
a psychotic illness being less likely to be offered psychological 
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Objectives: Technological advances in healthcare have shown promise when delivering interventions for mental health 
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in strand 3 of the study, the TechCare App will be examined in a feasibility study with 12 participants.
Conclusion: It has been suggested that there is a need for a rapid increase in the efforts to develop the evidence base for 
the clinical effectiveness of digital technologies, considering mHealth research can potentially be helpful in addressing the 
demand on mental health services globally.
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interventions.7 One way of tackling this poor access to treat-
ment is through the use of mobile and wireless technologies, 
which have the potential to transform mental healthcare. 
Globally, estimates suggest close to 5 billion mobile phone sub-
scriptions worldwide,8 with over 85% of the world’s popula-
tion being covered by a commercial wireless signal.8 In the 
United Kingdom, it is estimated that 93% of adults own/use a 
mobile phone, with 66% owning a smartphone.9
The emergence and continual development of technology in 
this era cannot be ignored, both socially, professionally, and per-
sonally technology encroaches upon all of our daily lives. 
Telehealth and mobile health (mHealth) are emerging fields in 
providing treatment and care globally.10–13 It involves the use of 
telecommunications to provide healthcare, support and inter-
ventions from a distance.14–16 Telehealth has been implemented 
into the treatment of chronic physical illnesses including diabe-
tes, congestive heart failure and asthma.16,17 Barak et al.18 found 
Internet-based interventions to be more successful for the treat-
ment of psychological problems than for physical or medical 
problems. Using technology to advance psychological treat-
ment is ‘a developing professional reality’.18
A study by Lester et al.19 showed the importance of tech-
nology in engagement within Early Intervention Services 
(EIS). This is important in drawing emphasis on how 
mHealth functions could provide continued support, but also 
give clients greater autonomy. Rotondi et al.20 found that for 
many clients, just having the access to support at their finger-
tips when needed was sufficient reassurance for them.
However, due to the current and developing nature of digi-
tal health technologies, these have faced criticism, such as the 
lack of interpersonal closeness when compared to face-to-
face intervention delivery. It has been reported that clients 
using a face-to-face intervention compared with an online 
chat overall felt more satisfied, a better sense of closeness and 
more comfortable in disclosing their difficulties.21,22 These 
criticisms are important to address, as each of these factors 
play key roles in contributing to a therapeutic relationship,23 
which has been highlighted as important in delivering effica-
cious treatment and encouraging engagement.19 However, in 
contrast, a meta-analysis of research on Internet-based psy-
chotherapeutic interventions found it to be as efficacious as 
face-to-face therapy in the treatment of certain mental health 
difficulties such as depression, anxiety and post-traumatic 
stress disorder.18 This shows that in many cases, the effective-
ness of the therapy is not diminished. Barak et al.18 found 
cognitive behavioural therapy (CBT) a much more effective 
therapy than others for online treatment of psychological dif-
ficulties. Furthermore, a systematic review by Alvarez-
Jimenez et al.24 found that mobile- and Internet-based 
interventions for psychosis were feasible and acceptable and 
have the potential to improve health outcomes.
A number of studies have shown support for the use of 
mHealth in severe mental illness.10,11,13,25 Palmier-Claus 
et al.11 reported that overall, 67% of participants preferred 
using a smartphone app compared to 13% who preferred Short 
Message Service (SMS) and 21% who had no preference on 
the delivery method. Furthermore, Granholm et al.10 reported 
that participants increased their level of socialisation, and 
there was also a reduction in severity of hallucinatory behav-
iour when using a low-level SMS-based intervention. The key 
findings of these studies were the feasibility and acceptability 
of mHealth Apps for Severe Mental Illnesses (SMIs) and the 
ability of mHealth technology to overcome barriers to access-
ing mental health treatment through the use of a non-stigma-
tising approach. Moreover, mHealth interventions as reported 
by Palmier-Claus et al.,11 Granholm et al.,10 and Ben-Zeev 
et al.13 are acceptable forms of intervention and thus provide a 
unique and beneficial platform for engagement.
mHealth innovations are important as they have the poten-
tial to bridge the ‘therapy-practice gap’,26 going beyond the 
confines of the therapy setting and bringing real-time treat-
ment in individual’s day-to-day lives and within their lived 
environments. The potential benefits of digital technologies 
in providing a new way to connect with health services and to 
potentially improve health outcomes are limited by a number 
of barriers in their use. Hollis et al.27 summarised these barri-
ers as the insufficient evidence base, limited uptake and out-
comes being anecdotal and unpublished. Hollis et al.27 further 
stated that for the potential of digital technologies to be fully 
realised, patients’ requirements need to be at the centre of 
developing interventions, and that there is a need for a rapid 
increase in the efforts to develop the evidence base for the 
clinical effectiveness of digital technologies.27
This project aims to integrate a momentary sampling 
assessment approach that is matched with a psychological 
intervention in real time to address low mood and paranoia. 
This proposal describes a feasibility project ‘Mobile 
Assessment and Therapy for Psychosis’ which is an inte-
grated mobile application which is provisionally titled 
‘TechCare’. Guidance regarding the development of new 
complex interventions suggests that it is appropriate to con-
duct a phase II or feasibility study.28 This study will follow 
guidance by the National Institute of Health Research29 on 
feasibility study design. Feasibility studies are conducted 
prior to conducting large studies in order to assess whether 
the study can be done. Vital parameters are examined that are 
needed to design the main study. The results of this feasibil-
ity study will inform the design of subsequent trials regard-
ing expected treatment effects, identification of appropriate 
outcome measures and follow-up periods, estimates of 
recruitment and feasibility of the intervention.
Aims and objectives
The proposed study aims to address the following 
questions:
1. Can appropriate individuals be identified and 
recruited to a trial for the evaluation of TechCare for 
psychosis?
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2. Will TechCare be an acceptable intervention for indi-
viduals with psychosis? Will they be able to engage 
in setting goals and reporting outcomes with care 
coordinators and work towards these with the 
TechCare App?
3. What would be the most appropriate primary out-
come measure for a future randomised controlled 
trial (RCT) of the TechCare intervention?
Methods
Design
We will use a mixed-methods design, which will consist of 
both qualitative and quantitative components. The study will 
be run across three strands as follows: (1) qualitative work, 
(2) test run and intervention refinement and (3) feasibility 
trial.
Inclusion criteria
The following inclusion criteria will be used:
•• The service user is receiving care from the Lancashire 
EIS.•• The service users between 18 and 35 years of age.•• There has been no change in the medication for at 
least 2 months prior to entry into the study.•• Clients must be currently stable; Lancashire Early 
Intervention Team uses a traffic light system to indi-
cate current symptomatology and risks of each client. 
Therefore, the clients who are considered to be stable 
according to this system will be eligible.•• A score of 3 or more on any of the positive symptoms 
on the Positive and Negative Syndrome Scale 
(PANSS) (e.g. delusions, hallucination).•• Minimum score of 1 on the Calgary Depression Scale.
Exclusion criteria
We will exclude patients meeting the following criteria:
•• Drug induced psychosis as determined by the indi-
vidual’s care team.•• An acquired brain injury or learning disability as 
determined by participant’s care team.•• Clients who are undergoing assessment, not formally 
diagnosed and accepted into the service.•• Lacking capacity for informed consent determined by 
the participant’s care team.
Recruitment
The research team will contact potential referrers (care coor-
dinators, clinical psychologists and psychiatrists) at the 
Lancashire EIS service. They will be provided with informa-
tion about the study and will be asked to share this with 
potential participants. In addition, information sessions will 
be offered by the research teams at the recruitment sites. If 
participants are interested and wish to be approached to 
receive further information about the research, a risk assess-
ment will be carried out with the care coordinator. This 
assessment will then inform the best way to approach 
participants.
We will also recruit health professionals such as care 
coordinators, clinical psychologists and EIS doctors from the 
Lancashire Care EIS and will adopt a purposive sampling 
strategy seeking to maximise the range of views accessed. 
We will leave participant information sheets with the clinical 
teams, so that potential participants can contact the research 
team directly.
A total of 16 qualitative interviews will be conducted with 
service users who will take part in strand 2 (test run) and 
strand 3 (feasibility trial). In addition, we will also carry out 
two focus groups with 8–10 health professionals (e.g. nurses, 
psychologists, psychiatrists and social workers). Interviews 
and focus groups will explore feasibility, acceptability and 
further development of the TechCare intervention.
Equipment
The TechCare software is being developed for use on a 
touchscreen mobile phone. The service users who have com-
patible smartphones will be able to upload the application to 
their phone. The team will lend a preloaded phone to those 
who wish to participate but do not have a smartphone. If par-
ticipants encounter any technical problems with their device, 
they will be advised to directly contact the research assistant 
(RA) or the principal investigator (PI).
Defining the intervention
EISs were introduced into the NHS in the early 1990s, for peo-
ple with a first episode of psychosis.19 Recent research shows 
that these services are cost-effective in reducing relapse and 
thus leading to reduction in hospital admissions.30,31 CBT is 
commonly used for the treatment of early psychosis32 and is a 
recommended treatment for first episode psychosis (National 
Institute of Health and Care Excellence (NICE)33). In the 
Lancashire Care NHS Foundation Trust (LCFT) EIS tier 1 
CBT is delivered by all care coordinators who have under-
taken the 3-day psychosocial intervention (PSI) training and is 
at the level of guided self-help interventions. These consist of 
understanding principles of recovery and hope, basic CBT 
thought–feeling–behaviour relationship, stress models, tech-
niques for managing mood, goal setting, SMART goals and 
relapse prevention. The intervention will be informed by the 
work of Kingdon and Turkington34 on CBT for psychosis. The 
TechCare intervention will be an add-on to treatment-as-usual 
(TAU), with the EIS team continuing the routine care of each 
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participant, which involves case management, medical treat-
ment and crisis planning. In addition, the RA will visit the par-
ticipant on a weekly basis.
Experiential sampling methodology
Experiential sampling methodology (ESM) is a structured 
methodology, with the capacity to examine the context and 
natural flow of daily occurrences in people’s lives. This is 
achieved by the real-time assessments of thoughts, feelings 
and events which are prompted at regular intervals within a 
day, typically via an electronic device (e.g. smartphone app). 
ESM has been used in psychosis with the aim of constructing 
an understanding of individual’s psychotic symptoms and 
the aetiological underpinnings of psychosis.35 ESM for psy-
chosis has also been validated by Palmier-Claus et al.,11 
which resulted in the development of the ClinTouch smart-
phone application. The ClinTouch system developed by 
Palmier-Claus et al.11 is a novel mobile assessment applica-
tion, which uses ESM technology to assess individual’s 
symptoms of psychosis. Based on this feasibility work, 
which reported that the ClinTouch system was safe, feasible 
and acceptable for individuals with psychosis, the ClinTouch 
team have furthered this work through the development of 
‘CareLoop’ which is a digital clinical system looking at 
long-term symptom monitoring of SMIs and is guided by 
qualitative input from service users and health profession-
als.36 The system prompts service users to respond to a num-
ber of structured questions about their symptoms. The key 
advantage of the system is that the data gathered is recorded 
in real time on a database, which is useful in monitoring 
symptoms and potentially allowing for warning signs to be 
highlighted to the team without delay.
Intelligent real-time therapy
There is a relatively large amount of research which suggests 
the efficacy of the use of mobile technologies to collect the 
longitudinal data on individual’s symptoms and views of 
their illness.37 However, there is little research suggesting the 
use of mobile devices to deliver psychological interven-
tions.38 One such concept which can be considered is called 
intelligent real-time therapy (iRTT). This conceptual model 
outlines the use of mobile technologies to deliver interven-
tions for mental health problems. This system goes beyond 
the momentary assessment of symptoms, by also providing 
service users with a remotely delivered psychological inter-
vention such as CBT to help reduce the distress being expe-
rienced due to their symptoms.26
The proposed TechCare App will use a combination of 
ESM and iRTT. The system will also use differing iRTT 
media formats to convey user-preferred video messages, 
recordings, text messages, poems and images, providing an 
interactive interface for service users to engage with and pos-
sibly provide better engagement with health professionals.
Strand 1: qualitative component
1. In-depth interviews. A total of 16 service users who 
consent to take part in the study will be asked to take 
part in semi-structured interviews, in order to obtain 
insight into the experience of the TechCare interven-
tion. The semi-structured interviews with the partici-
pants will be digitally recorded and will be transcribed 
verbatim.
2. Focus group. We will conduct two focus groups with 
8–10 health professionals (e.g. nurses, psychologists, 
psychiatrists and social workers) who work with ser-
vice users who experience psychosis. The focus 
groups will also be digitally recorded and transcribed 
verbatim. We will look to explore the health profes-
sional’s views on the intervention and possible areas 
which may need to be refined in preparation for 
strands 2 and 3.
Strand 2: test run and intervention refinement
In this phase, we will conduct a test run of the TechCare 
intervention which will last for duration of 2 weeks, with a 
small group of four participants who will be recruited from 
Lancashire Care EIS. This will allow us to preliminarily test 
the intervention. We will gather feedback from the partici-
pating individuals, therapists and the clinical staff (psychia-
trist/care coordinators) on the relevance and acceptability of 
the TechCare approach. This will inform the further refine-
ment of the intervention to the local context and how best to 
run the TechCare intervention in the feasibility trial. We will 
undertake semi-structured, one-to-one interviews with all 
participants in the test run to obtain their opinions on the 
intervention, its feasibility, acceptability, impact on their 
lives and their thoughts about the role of the intervention in 
reducing symptoms of psychosis. All interviews and focus 
groups will be carried out by one member of the research 
team (N.G.); these interviews will be digitally recorded and 
subsequently transcribed.
The interview schedule will include pre-determined ques-
tions (based on findings from strand 1) but will also include 
open-ended questions to facilitate emergence of new themes. 
We will investigate the acceptability of the treatment through 
addressing themes such as participant’s expectations of the 
intervention, factors associated with therapeutic alliance, its 
relevance to their psychotic symptoms, problems and social 
circumstances, their experience of the delivery method, what 
they found helpful or less helpful and potential changes that 
could be made to improve their overall experience of the 
TechCare intervention.
Refinement. The team will collate the quantitative data and 
qualitative data from this strand and work with the software 
development team to refine the intervention and delivery of 
the TechCare intervention.
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Strand 3: feasibility trial
A total of 12 service users will be recruited from the 
Lancashire EIS for the feasibility trial. Each client’s care 
coordinator will play a key role in the development of indi-
vidualised tier 1 psychological interventions.
Outcome measures
PANSS (for schizophrenia).39 This is a clinician adminis-
tered 30-item semi-structured interview which provides 
balanced representation of positive symptoms and nega-
tive symptoms over a 2-week period and gauges their 
relationship to one another and to global/general psycho-
pathology. The use of PANSS in mHealth interventions 
has been validated by Palmier-Claus et al.11 through the 
ClinTouch application.
The Psychotic Symptom Rating Scales (PSYRATS).40 The 
PSYRATS is a semi-structured interview, measuring 
dimensions of delusions and hallucinations. The instru-
ment has been validated against the PANSS by Drake 
et al.41
CHoice of Outcome In Cbt for psychosEs (CHOICE).42 This 
is an outcome measure which reflects the aims of CBT for 
psychosis and the priorities of service users. It was devel-
oped with service users, and this shortened version is being 
utilised in the National IAPT for psychosis programme. 
Lancashire Care EIS is one of two national demonstration 
sites for the programme in the United Kingdom.
Warwick-Edinburgh Mental Well-Being Scale 
(WEMWBS).43 The WEMWBS is a measure of mental 
well-being, which focuses entirely on positive aspects of 
mental health. It consists of 14 items on one page, is quick 
to administer and is psychometrically robust.44 It is also a 
core measure with the IAPT for psychosis project and will 
measure improvements in positive aspects of mental 
health, as a result of the TechCare mobile application.
Brief Core Schema Scales (BCSS).45 This is a 24-item 
measure of core beliefs regarding self and others. Four 
scores are obtained; negative self, positive self, negative 
others and positive others. Fowler et al.45 found the BCSS 
to have good psychometric properties.
Calgary Depression Scale (CDS).46 The CDS was devel-
oped to measure the level of depression in schizophrenia. 
It is a 9-item scale which allows for the quantitative and 
subjective dimensions of depression in schizophrenia; 
items are scored on a scale of 0–4 with a minimum score 
of 0 and maximum score of 27 for an assessment. The 
CDS is psychometrically robust and has been validated 
against the Hamilton Depression Scale.47
The Work and Social Adjustment Scale (WSAS).48 This is 
a 5-item measure of perceived impairment in five areas: 
work, home management, social life, private leisure and 
relationships. Each item is scored from 0 (no impairment) 
to 8 (very severe impairment) with a total score of 40.
EuroQoL-5 Dimensions (EQ5-D). Health-related quality 
of life will be measured using the EuroQoL-5 Dimensions 
(EQ-5D);49 the measure is a standardised instrument 
looking at quality of life across five health domains 
(mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression). The measure has been widely used 
in psychosis research.
TechCare application assessment 
questions
A range of unusual or paranoid beliefs are reported by indi-
viduals with psychosis. The TechCare App will be equipped 
with a ‘delusions’ and ‘mood’ menu in the setup section 
(adapted from Palmier-Claus et al.11), where the researcher 
or case manager can personalise which delusions the partici-
pant is currently experiencing based on the initial PANSS 
interview and other self-report questionnaires. This delu-
sional belief will be the basis for TechCare questions asked 
and scored for level of preoccupation, distress and impact on 
behaviour. Up to two personalised delusions can be entered 
for each person. For those with more, the delusions with 
greatest conviction and distress rating will be utilised. We 
will also include items from the Calgary Depression Scale to 
assess mood. Depending on the threshold of response, the 
assessment question will trigger the intervention screen for 
that specific difficulty. The intervention screen will display a 
list of personalised self-help interventions such as thought–
feeling–behaviour relationships, stress models, techniques 
for managing mood and goal setting, which will be informed 
by the work of Kingdon and Turkington34 on CBT for psy-
chosis and participant tailored iRTT media (music, images 
and video clips) (see Figure 1). In this feasibility study, the 
personalised self-help interventions will be available to par-
ticipants at all times in response to the symptoms reported. 
The TechCare self-help intervention is designed only to test 
the intervention to address symptoms of low mood and para-
noia, with all responses made by the participant being 
recorded in real time through the App. The participants will 
also be able to access some materials on psychoeducation34 
and also some other helpful links, along with the routine EIS 
treatment which includes a crisis plan.
The TechCare App ESM and iRTT system will utilise 
intelligence at two levels:
1. Intelligently increasing the frequency of assessment 
notifications if low mood/paranoia is detected. This 
will be done through feedback loops which monitor 
symptoms over time, with the deployment of a per-
sonalised crisis plan, if prolonged duration of low 
mood/paranoia is detected (≃4 h).
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2. An intelligent machine learning algorithm which 
provides interventions in real time based on breach 
of assessment thresholds and also provides recom-
mendations on the most popular interventions. 
Recommendations will be based on most selected 
interventions by the cohort of participants on the 
study, with the most popular listed interventions in 
rank order.
A total of three notifications will be sent between 10 a.m. 
and 10 p.m. If low mood/paranoia is detected by the App, it 
will re-notify the participant every 60 min to assess symp-
toms in real time with personalised interventions being dis-
played to participants. The system will re-notify participants 
a total of three times with an agreed crisis response being 
displayed on the App if low mood/paranoia is detected for a 
prolonged duration of time (a period of ≃4 h). Crisis plan-
ning is a routine part of EIS treatment with all service users 
working with their health professionals to agree a plan of 
action which they can follow if they are in crisis. The crisis 
plan will also be displayed via the TechCare App. The crisis 
response will consist of an agreed plan of action in the case 
participants are in distress due to their symptoms and will 
also prompt the participant to contact the EIS service or an 
agreed designated contact. In the feasibility context, we will 
examine response rates to questions and notifications and 
also the participant’s selection of the intervention. The 
researcher and case manager will be able to view participant 
responses and selection of interventions by the participant 
over the intervention period; this data will hold important 
insights into the feasibility of the intervention.
Adverse event reporting
The research team will adhere to principles of Good Clinical 
Practice in reporting adverse events.50 The adverse events in 
digital interventions are generally not well reported, as we 
have described previously.51 Monitoring of any serious 
adverse events (SAEs) will be carried out throughout the 
study. The PI N.H. will be directly notified of all adverse 
events, with all SAEs being reported to the NHS Research 
Ethics Committee (REC). In the light of the limited literature 
on adverse events in digital technology,51,52 we will explore 
these further through the strand 1 qualitative interviews and 
the data on the side effects such as worsening of symptoms 
and/or mood which will be assessed at the weekly review 
assessment and will be reported to the case manager.
Results
The trial is currently ongoing, and we have completed two 
focus groups with health professionals and some qualitative 
interviews with participants, who are participating in the 
strand 2: test run and intervention refinement component.
Proposed analysis strategy
Quantitative data analysis. All analyses will be conducted 
using SPSS v20, with preliminary analysis, being conducted 
where appropriate. We will compare baseline and post-inter-
vention scores on the primary and secondary outcome meas-
ures. In the feasibility context, we aim to test our hypothesis 
that TechCare does not lead to poorer outcomes, that is, that 
the post-intervention scores are at least no worse than at 
pre-test.
Qualitative data analysis. Once the interviews and focus 
groups have been completed, these will be fully transcribed in 
order to be analysed. We will look for themes emerging in 
areas of feasibility, acceptability and further development. All 
of these aspects will provide insight to develop the interven-
tion further and test in a future RCT. The qualitative data will 
be analysed using a framework analysis.53 We will analyse 
each individual transcript by identifying and highlighting 
portions or sections of the data relating to important or emerg-
ing themes. We will then compare and contrast these themes 
from across transcripts to find common ones and then com-
bine similar themes into more general themes and sub-themes 
taking into account data from the whole data set. The data in 
its original textual context will then be placed under the head-
ings and subheadings of the themes and sub-themes and will 
be used to form a conceptual framework. The process of 
framework analysis will be ongoing throughout the data 
Figure 1. An example of ESM and iRTT in the TechCare App.
Husain et al. 7
collection period. Any discrepancies will be resolved through 
discussion within the research team, with the final themes and 
findings being read for congruence and reliability.54
Discussion/conclusion
Technology is increasing at an exponential rate with digital tech-
nologies providing a key platform for the delivery of improved 
health outcomes. The proposed research is a feasibility project, 
which aims to examine the feasibility and acceptability of the 
TechCare intervention. The intervention is based on sound the-
ory derived from earlier research.10,25,26 We have also closely fol-
lowed the guidance by the National Institute of Health Research29 
in designing feasibility studies to test the vital parameters which 
will inform the design of a definitive trial.
Rees and Stone55 found that clinical psychologists rated 
therapeutic alliance lower in the videoconferencing condi-
tion than the face-to-face intervention. This shows that thera-
peutic alliance may be lesser developed within mHealth 
interventions than face-to-face intervention, which could 
have a negative impact on treatment. However, Cook and 
Doyle21 found that clients reported feeling satisfied with the 
therapeutic alliance within an online therapy intervention. 
Moreover, the TechCare intervention has the potential to 
overcome some of these criticisms as it intertwines mHealth 
with existing therapeutic relationships (client’s relationships 
with their care team), potentially enhancing rather than limit-
ing the therapeutic capacity of the relationship. The mHealth 
intervention will have other advantages which can offset the 
disadvantage due to lack of face-to-face contact. The avail-
ability of the intervention at all times in contrast to limited 
time with the therapist and the flexibility in the use of the 
intervention are potential advantages. Furthermore, a study 
by Lester et al.19 showed the importance of technology in 
engagement within EIS. This is important in drawing empha-
sis on how mHealth functions could provide continued sup-
port, but also give clients greater autonomy.
The study has been designed with a focus on implementa-
tion from the outset and has engaged with the target audience 
in each step of developing the intervention. The service users 
were involved in developing the protocol, obtaining ethics 
for the study and also assisted in the development of the lay-
out and overall design of the intervention.
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